Search Results - Barraco, Marilena

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    The human Smoothened inhibitor PF-04449913 induces exit from quiescence and loss of multipotent Drosophila hematopoietic progenitor cells

    The human Smoothened inhibitor PF-04449913 induces exit from quiescence and loss of multipotent Drosophila hematopoietic progenitor cells by Giordani, Giorgia, Barraco, Marilena, Giangrande, Angela, Martinelli, Giovanni, Guadagnuolo, Viviana, Simonetti, Giorgia, Perini, Giovanni, Bernardoni, Roberto

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Nuclear translocation of PKC‐ α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)

    Nuclear translocation of PKC‐ α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) by Poli, Alessandro, Ratti, Stefano, Finelli, Carlo, Mongiorgi, Sara, Clissa, Cristina, Lonetti, Annalisa, Cappellini, Alessandra, Catozzi, Alessia, Barraco, Marilena, Suh, Pann‐Ghill, Manzoli, Lucia, McCubrey, James A., Cocco, Lucio, Follo, Matilde Y.

    Published in The FASEB journal
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Notch signaling during development requires the function of awd, the Drosophila homolog of human metastasis suppressor gene Nm23

    Notch signaling during development requires the function of awd, the Drosophila homolog of human metastasis suppressor gene Nm23 by Ignesti, Marilena, Barraco, Marilena, Nallamothu, Gouthami, Woolworth, Julie A, Duchi, Serena, Gargiulo, Giuseppe, Cavaliere, Valeria, Hsu, Tien

    Published in BMC biology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

    Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy by Follo, Matilde Y, Pellagatti, Andrea, Armstrong, Richard N, Ratti, Stefano, Mongiorgi, Sara, Astolfi, Annalisa, Indio, Valentina, Clissa, Cristina, Russo, Domenico, Gobbi, Marco, Barraco, Marilena, Parisi, Sarah, Pession, Andrea, Cavo, Michele, Manzoli, Lucia, Cocco, Lucio, Boultwood, Jacqueline, Finelli, Carlo

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Role of Nuclear Inositide Signalling and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

    Role of Nuclear Inositide Signalling and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy by Follo, Matilde, Mongiorgi, Sara, Clissa, Cristina, Astolfi, Annalisa, Russo, Domenico, Gobbi, Marco, Bosi, Costanza, Crugnola, Monica, Stanzani, Marta, Ratti, Stefano, Parisi, Sarah, Barraco, Marilena, Manzoli, Lucia, Pession, Andrea, Cocco, Lucio, Finelli, Carlo

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study

    Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study by Finelli, Carlo, Clissa, Cristina, Follo, Matilde, Stanzani, Marta, Parisi, Sarah, Mongiorgi, Sara, Barraco, Marilena, Avanzini, Paolo, Bosi, Costanza, Castagnari, Barbara, Candoni, Anna, Crugnola, Monica, Giannini, Maria Benedetta, Gobbi, Marco, Leonardi, Giovanna, Rigolin, Gian Matteo, Russo, Domenico, Tosi, Patrizia, Visani, Giuseppe, Cocco, Lucio, Cavo, Michele

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: